Peter Glazer is listed as a director and promoter on 2 SEC Form D filings by 1 issuer between Mar 2009 and Dec 2010: Helix Therapeutics, Inc. (New Haven, CT — biotechnology — 2009–2010; $2.5M reported sold to 2 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Gerald Vovis (2 shared filings), Joseph Catino (2 shared filings), Kevin Rakin (2 shared filings), Ranjit Bindra (2 shared filings), Russell E. Tweeddale (2 shared filings) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Peter Glazer and found 3 differences: Peter Glazer's role changed at Helix Therapeutics, Inc.: director → director, promoter; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.